CRISPR/Cas9 editing in human pluripotent stemcell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
View/ Open
Volume
39
Pagination
3879 - +
DOI
10.1093/eurheartj/ehy249
Journal
EUROPEAN HEART JOURNAL
Issue
ISSN
0195-668X